SCHEMBL3038534

SCHEMBL3038534

CCCCC(=O)OCC(COC(=O)CCCC)OC(=O)CCCC

nearest known ligand 0.86

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.86
LMNA P02545 1/20 0.86
PRKCA P17252 4/20 0.72
PRKCE Q02156 2/20 0.72
PRKCQ Q04759 2/20 0.72
PRKCD Q05655 2/20 0.72
LPAR3 Q9UBY5 7/20 0.67
LPAR1 Q92633 4/20 0.67
ENPP2 Q13822 3/20 0.67
SMN1; SMN2 Q16637 1/20 0.67
LPAR2 Q9HBW0 2/20 0.65
CYP3A4 P08684 1/20 0.58
TSHR P16473 1/20 0.58
ATM Q13315 1/20 0.58
TDP1 Q9NUW8 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17866509 0.96 ALDH1A1 (0.80) ALDH1A1LMNAPRKCAPRKCEPRKCQ
SCHEMBL17866515 0.96 ALDH1A1 (0.80) ALDH1A1LMNAPRKCAPRKCEPRKCQ
SCHEMBL17866524 0.94 ALDH1A1 (0.77) ALDH1A1LMNAPRKCAPRKCEPRKCQ
SCHEMBL18954279 0.94 ALDH1A1 (0.96) ALDH1A1LMNAPRKCAPRKCEPRKCQ
SCHEMBL177730 0.94 ALDH1A1 (0.96) ALDH1A1LMNAPRKCAPRKCEPRKCQ
SCHEMBL21479791 0.93 ALDH1A1 (0.75) ALDH1A1LMNAPRKCAPRKCEPRKCQ
SCHEMBL17866519 0.93 ALDH1A1 (0.75) ALDH1A1LMNAPRKCAPRKCEPRKCQ
SCHEMBL24333843 0.92 ALDH1A1 (1.00) ALDH1A1LMNAPRKCAPRKCEPRKCQ
SCHEMBL24334040 0.92 ALDH1A1 (1.00) ALDH1A1LMNAPRKCAPRKCEPRKCQ
Tripalmitin SCHEMBL2017107 0.92 ALDH1A1 (1.00) ALDH1A1LMNAPRKCAPRKCEPRKCQ

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 93 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260130395-A1 Water Dispersible Botanical Compositions AQUILA BLACK LTD (AU) 2026-05-14 US claimed
EP-4352039-B1 MIXED GLYCEROL ESTER COMPOSITION PERSTORP AB (SE) 2025-12-24 EP claimed
WO-2025120610-A1 LIQUID/SOLID HYBRID MATERIALS AS STABILIZED BROMOFORM AND OTHER ANTI-METHANOGENIC FORMULATIONS FOR ADMINISTRATION TO RUMINANTS Loam Bio Pty Ltd (AU) 2025-06-12 WO claimed
US-20250144021-A1 GEL FORMULATIONS FOR LOCAL DRUG RELEASE TECHNICAL UNIVERSITY OF DENMARK (DK) 2025-05-08 US claimed
EP-4529468-A1 FORMULATION OF API'S AND EXCIPIENT'S IN AN ICELL VIA HYDROPHOBIC ION PAIRING Danmarks Tekniske Universitet (DK) 2025-04-02 EP claimed
EP-4529477-A1 POROUS EXPANDING BIOCOMPATIBLE SCAFFOLDS Danmarks Tekniske Universitet (DK) 2025-04-02 EP claimed
WO-2025046052-A1 A NOVEL ANIMAL FEED ADDITIVE COMPOSITION PERSTORP AB (SE) 2025-03-06 WO claimed
US-12226527-B2 Gel formulations for local drug release TECHNICAL UNIVERSITY OF DENMARK (DK) 2025-02-18 US claimed
US-20240415914-A1 Water Dispersible Cannabinoid Compositions AQUILA BLACK LTD (AU) 2024-12-19 US claimed
US-20240277651-A1 MIXED GLYCEROL ESTER COMPOSITION PERSTORP AB (SE) 2024-08-22 US claimed
EP-4352039-A1 MIXED GLYCEROL ESTER COMPOSITION Perstorp AB (SE) 2024-04-17 EP claimed
WO-2023227517-A1 FORMULATION OF API'S AND EXCIPIENT'S IN AN ICELL VIA HYDROPHOBIC ION PAIRING DANMARKS TEKNISKE UNIVERSITET (DK) 2023-11-30 WO claimed
WO-2023227518-A1 POROUS EXPANDING BIOCOMPATIBLE SCAFFOLDS DANMARKS TEKNISKE UNIVERSITET (DK) 2023-11-30 WO claimed
EP-4282448-A1 POROUS EXPANDING BIOCOMPATIBLE SCAFFOLDS Danmarks Tekniske Universitet (DK) 2023-11-29 EP claimed
WO-2023070172-A1 WATER DISPERSIBLE BOTANICAL COMPOSITIONS Aquila Black Limited (AU) 2023-05-04 WO claimed
WO-2023070170-A1 WATER DISPERSIBLE CANNABINOID COMPOSITIONS Aquila Black Limited (AU) 2023-05-04 WO claimed
CN-115948005-A PVC cable material with flame retardant property and preparation method thereof 张燕军 2023-04-11 CN claimed
CN-115531228-A Cosmetic composition for improving hair containing no siloxane UCL株式会社 2022-12-30 CN claimed
WO-2022260568-A1 MIXED GLYCEROL ESTER COMPOSITION PERSTORP AB (SE) 2022-12-15 WO claimed
US-20220296560-A1 PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION IN POWDER FORMULATION CONTAINING ANTIVIRAL AGENT DAE HWA PHARMA. CO., LTD. (KR) 2022-09-22 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220296560-A1 PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION IN POWDER FORMULATION CONTAINING ANTIVIRAL AGENT LIPC, GK, LIPA ALDH1A1 2927/4885LMNA 3281/4885PRKCA 1532/4885
US-20260130395-A1 Water Dispersible Botanical Compositions TTPA, PNLIP, SRMS ALDH1A1 2919/4885LMNA 1292/4885PRKCA 559/4885
US-20250144021-A1 GEL FORMULATIONS FOR LOCAL DRUG RELEASE TREH, GALE, SLC2A8 ALDH1A1 3664/4885LMNA 4434/4885PRKCA 2489/4885
US-12226527-B2 Gel formulations for local drug release TREH, GALE, SLC2A8 ALDH1A1 3664/4885LMNA 4434/4885PRKCA 2489/4885
US-20240415914-A1 Water Dispersible Cannabinoid Compositions CNR1, CNR2, CDIPT ALDH1A1 2853/4885LMNA 2438/4885PRKCA 1786/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.